Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study

RSF significantly improved DFS prediction compared with Cox regression and yielded the best discriminatory performance in both training and external validation cohorts. These findings highlight the value of ML-based survival models, particularly RSF, for enhancing individualized postoperative prognostication and refining patient selection for clinical trials evaluating adjuvant treatment to surveillance after LR for HCC.

Authors

Institutions

Publication Details

Journal
Liver Cancer
Published
2026-01-30
DOI
https://doi.org/10.1159/000550554
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study

Julien Caldéraro, Cyprien Toubert, Perrine Zimmermann, R. Kianmanesh et al.
Liver Cancer
Hepatocellular Carcinoma Treatment and Prognosis
article

Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study

Julien Caldéraro, Cyprien Toubert, Perrine Zimmermann, R. Kianmanesh, Paradis, Astrid Herrero, Rudy Merieux, Marie Alaux, Hélène Regnault, Camille Boulagnon-Rombi, Mickael Lesurtel, Safi Dokmak, Alexandra Heurgué, Rami Rhaiem, Ammar Abdo, Olivier Soubrane, Raffaele Brustia, Stefano Caruso, Daniele Sommacale, Alain Luciani, Giuliana Amaddeo
article en

Abstract

RSF significantly improved DFS prediction compared with Cox regression and yielded the best discriminatory performance in both training and external validation cohorts. These findings highlight the value of ML-based survival models, particularly RSF, for enhancing individualized postoperative prognostication and refining patient selection for clinical trials evaluating adjuvant treatment to surveillance after LR for HCC.

Liver Cancer
Inserm (FR), Université Paris-Est Créteil (FR), Université de Montpellier (FR), Université Paris Cité (FR), Hôpital Beaujon (FR), Institute Mutualiste Montsouris (FR), Centre Hospitalier Universitaire de Montpellier (FR), Assistance Publique – Hôpitaux de Paris (FR), Centre Hospitalier Universitaire de Reims (FR), Centre de Recherche sur l'Inflammation (FR), Hôpitaux Universitaires Henri-Mondor (FR), Institut Mondor de Recherche Biomédicale (FR), Université de Reims Champagne-Ardenne (FR)
Reduced inequalities
Openalex Percentile: Top 70%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.